Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Mar 4;17(2):215–224. doi: 10.1016/j.neo.2014.12.011

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Figure S3 — Phenotypic analysis of NU12 tumors.

Phenotypic analysis of NU12 tumors of mice treated with sunitinib. Mice were injected intravenously with ¹¹¹In-Girentuximab (0.4 MBq, 5 μg) 3 days pre-sunitinib treatment. Accumulation of Girentuximab remained unchanged when sunitinib followed Girentuximab injection. Tumors shown were harvested at Day 7 (4 days after start of sunitinib treatment). A, C: HE staining of untreated and sunitinib treated tumor respectively; B, D: Girentuximab accumulation. Original magnification X25 and X200.